Skip to main content Skip to main navigation menu Skip to site footer
Journal of Commercial Biotechnology
  1. Home /
  2. Archives /
  3. Vol. 14 No. 2 (2008)

Vol. 14 No. 2 (2008)

Published: 2008-04-01

Editorial

  • Editorial

    Yali Friedman
    • PDF

Article

  • Export compliance for life sciences

    John Avellanet
    • PDF
  • A new approach to improve technology commercialisation in university medical schools

    Courtney Price, Richard Huston, Arlen D Meyers
    • PDF
  • Biotechnology business models work: Evidence from the pharmaceutical marketplace

    J Leslie Glick
    • PDF
  • Valuing biotechnology companies: Does classification by technology type help?

    Jacqueline Loh, Robert Brooks
    • PDF
  • Risk management for the biotechnology industry: A Canadian perspective

    Sandra Vanderbyl, Sherry Kobelak
    • PDF
  • Singapore's biomedical sciences landscape

    Keat-Chuan Yeoh
    • PDF
  • Social responsibility for the use of genes, genomes and biotechnology in biotechnology companies: A commentary from the bioethical viewpoint

    Yoshihiro Okada, Kazuo N Watanabe
    • PDF

Legal and Regulatory Updates

  • Legal and regulatory update

    Gerry Kamstra, John Wilkinson
    • PDF

Conference Report

  • Maryland and Virginia unite at 2007 Mid-Atlantic Bio Conference

    Harley King
    • PDF

Book Review

  • Book Review: Stem cell wars: Inside stories from the Frontlines

    Grant H Skrepnek
    • PDF

Copyright © 2021
Journal of Commercial Biotechnology
All rights reserved.
ISSN: 1462-8732 | eISSN: 1478-565X

Privacy Policy

Journal of Commercial Biotechnology

GoDaddy SiteSeal WebTrust